JP2023545017A5 - - Google Patents

Info

Publication number
JP2023545017A5
JP2023545017A5 JP2023520341A JP2023520341A JP2023545017A5 JP 2023545017 A5 JP2023545017 A5 JP 2023545017A5 JP 2023520341 A JP2023520341 A JP 2023520341A JP 2023520341 A JP2023520341 A JP 2023520341A JP 2023545017 A5 JP2023545017 A5 JP 2023545017A5
Authority
JP
Japan
Prior art keywords
sftpb
cyfra21
reporter molecule
pro
cea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023520341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023545017A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052611 external-priority patent/WO2022072471A1/en
Publication of JP2023545017A publication Critical patent/JP2023545017A/ja
Publication of JP2023545017A5 publication Critical patent/JP2023545017A5/ja
Pending legal-status Critical Current

Links

JP2023520341A 2020-10-02 2021-09-29 肺がんの検出及び治療のための方法 Pending JP2023545017A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063086865P 2020-10-02 2020-10-02
US63/086,865 2020-10-02
US202063106187P 2020-10-27 2020-10-27
US63/106,187 2020-10-27
PCT/US2021/052611 WO2022072471A1 (en) 2020-10-02 2021-09-29 Methods for the detection and treatment of lung cancer

Publications (2)

Publication Number Publication Date
JP2023545017A JP2023545017A (ja) 2023-10-26
JP2023545017A5 true JP2023545017A5 (enExample) 2024-10-07

Family

ID=80950972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023520341A Pending JP2023545017A (ja) 2020-10-02 2021-09-29 肺がんの検出及び治療のための方法

Country Status (6)

Country Link
US (1) US20240159753A1 (enExample)
EP (1) EP4222287A4 (enExample)
JP (1) JP2023545017A (enExample)
KR (1) KR20230080442A (enExample)
CA (1) CA3163498A1 (enExample)
WO (1) WO2022072471A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2995959T3 (en) * 2017-02-09 2025-02-11 Univ Texas Methods for the detection and treatment of lung cancer
GB2603051B (en) 2020-01-30 2023-04-26 Prognomiq Inc Lung biomarkers and methods of use thereof
GB2607436A (en) * 2021-03-31 2022-12-07 Prognomiq Inc Multi-omic assessment
AU2022249074A1 (en) 2021-03-31 2023-09-21 PrognomIQ, Inc. Multi-omic assessment
WO2023039479A1 (en) 2021-09-10 2023-03-16 PrognomIQ, Inc. Direct classification of raw biomolecule measurement data
JP2024534992A (ja) 2021-09-13 2024-09-26 プログノミック インコーポレイテッド 生体分子の増強された検出および定量
WO2024107923A1 (en) * 2022-11-17 2024-05-23 Board Of Regents, The University Of Texas System Methods for the detection and treatment of lung cancer
JP2026520689A (ja) * 2023-05-31 2026-06-24 ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム 肺癌の検出及び治療方法
GB202310137D0 (en) * 2023-07-03 2023-08-16 Belgian Volition Srl Method for the detection of cancer
EP4781412A2 (en) * 2023-09-22 2026-07-29 Board of Regents, The University of Texas System Methods for the detection and treatment of lung cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004081569A1 (ja) * 2003-03-11 2004-09-23 Trans Genic Inc. 腫瘍マーカーとしてのｎ１，ｎ１２－ジアセチルスペルミン
AU2007205234B2 (en) * 2006-01-05 2012-07-12 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
JP5905003B2 (ja) * 2010-07-09 2016-04-20 ソマロジック・インコーポレーテッド 肺癌バイオマーカーとその使用
WO2013154998A1 (en) * 2012-04-09 2013-10-17 Duke University Serum biomarkers and pulmonary nodule size for the early detection of lung cancer
US9753037B2 (en) * 2013-03-15 2017-09-05 Rush University Medical Center Biomarker panel for detecting lung cancer
CN108139381A (zh) * 2015-06-26 2018-06-08 百奥马克癌症系统公司 肺癌检测方法
CN109478231A (zh) * 2016-04-01 2019-03-15 20/20基因系统股份有限公司 帮助区别良性和恶性放射线照相明显肺结节的方法和组合物
EP3361256A1 (en) * 2017-02-08 2018-08-15 Fundación para la Investigación Médica Aplicada In vitro method for the diagnosis of lung cancer
ES2995959T3 (en) * 2017-02-09 2025-02-11 Univ Texas Methods for the detection and treatment of lung cancer

Similar Documents

Publication Publication Date Title
US20240361322A1 (en) Lung cancer biomarkers
TWI698639B (zh) 前列腺抗原標準品及其用途
JP2020510816A5 (enExample)
KR101520615B1 (ko) 간암 진단용 바이오 마커
CA2792163A1 (en) Biomarkers of osteoarthritis
US20240027456A1 (en) Lung cancer biomarkers
JPWO2016163539A1 (ja) 肝疾患の病態を判別する方法
US20240151726A1 (en) Diagnostic methods for liver disorders
US20230358764A1 (en) Diagnostic methods for liver disorders
CN113567687A (zh) 检测样品中两种生物标志物的表达水平的试剂在制备用于检测子痫前期试剂盒中的应用
EP2784511A1 (en) Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma
JP7650538B2 (ja) 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法
US8053198B2 (en) Diagnostic methods
CN114814243A (zh) 应用于蛋白质抗原的定量检测试剂盒及方法
KR20230113742A (ko) 난소암의 검출 및 치료를 위한 방법
CN120210363A (zh) 用于诊断晚期鼻咽癌的生物标志物及其应用
KR101144324B1 (ko) 대장암 예후진단용 단백질 마커 디펜신?５와 ｒｏｄ１단백질의 조합 및 이들 각각에 대한 항체를 포함하는 대장암 예후진단키트
KR102407703B1 (ko) 반려동물의 종양 질병을 보조적으로 진단하는 바이오마커 검사방법
CN109154612B (zh) 生物样品中磷酸化和非磷化形式的rkip的定量评估方法
US20220299514A1 (en) Biomarkers of therapeutic responsiveness
KR101859812B1 (ko) 간암 화학 색전술 치료 예후 예측을 위한 바이오마커 및 그 용도
WO2023230584A1 (en) Methods and systems for risk stratification and management of bladder cancer
CN113981092A (zh) 用于预测肿瘤药物敏感性的生物标志物及其相关产品
US20250110132A1 (en) Biomarkers for the determination of sample adequacy and lung cancer metastases
Sorio et al. Non‐invasive cancer detection: Strategies for the identification of novel cancer markers